IBOV 187,422.92 ▲ 0.44% IPSA 11,426.83 ▲ 0.61% IPC MEX 64,456.59 ▲ 1.45% MERVAL 2,997,659 ▼ 0.04% COLCAP 2,588.64 ▲ 0.90% BVL PERÚ 59,529.36 ▲ 1.84% USD/BRL5.11▲ 0.10% USD/MXN17.35▲ 0.33% USD/CLP943.65▼ 0.59% USD/COP3,204— 0.00% USD/PEN3.38▲ 0.07% USD/ARS1,514▼ 0.02% USD/UYU40.06▲ 2.88% USD/PYG5,918▲ 3.14% USD/BOB11.85▲ 25.24% USD/DOP59.28▲ 0.82% USD/CRC445.27▲ 2.84% USD/GTQ7.63▲ 3.24% USD/HNL26.86▲ 3.32% USD/NIO36.62▲ 2.68% USD/VES851.37— 0.00% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD 157.28 — 0.00% USD/TTD6.74▲ 2.48% EUR/BRL5.83▼ 0.39% BRENT 88.88 ▼ 0.03% WTI 83.11 ▼ 0.11% IRON ORE 161.91 — — COPPER 6.61 ▲ 0.03% GOLD 4,461 ▲ 1.78% SILVER 65.59 ▲ 1.26% SOY 1,184 ▲ 3.20% CORN 480.50 ▲ 10.02% WHEAT 655.00 ▲ 3.93% COFFEE 317.25 ▼ 5.51% SUGAR 16.43 ▼ 1.79% ORANGE JUICE 138.55 ▼ 0.47% COTTON 85.03 ▲ 2.33% COCOA 5,719 ▲ 3.18% BEEF 223.60 ▼ 3.93% CATTLE 339.10 ▼ 3.16% LITHIUM 75.20 ▲ 1.47% PETR4 41.64 ▼ 0.05% VALE3 72.97 ▲ 0.83% ITUB4 38.60 ▼ 1.03% BBDC4 16.85 ▲ 0.36% ABEV3 14.89 ▼ 0.80% BBAS3 19.37 ▲ 0.47% B3SA3 14.26 ▼ 0.21% WEGE3 47.59 ▲ 0.49% PRIO3 59.14 ▼ 0.19% SUZB3 41.33 ▲ 2.35% RENT3 34.68 ▼ 0.09% AZZA3 15.89 ▼ 2.63% CSAN3 3.22 ▼ 1.83% RAIZ4 0.25 — 0.00% PCAR3 2.75 ▼ 0.36% GMAT3 3.65 ▼ 1.08% PSSA3 48.13 ▼ 0.54% CVCB3 1.33 ▼ 2.92% POSI3 3.36 ▲ 2.44% SLCE3 13.34 ▲ 0.30% NATU3 8.14 ▼ 0.73% IBOV 187,422.92 ▲ 0.44% IPSA 11,426.83 ▲ 0.61% IPC MEX 64,456.59 ▲ 1.45% MERVAL 2,997,659 ▼ 0.04% COLCAP 2,588.64 ▲ 0.90% BVL PERÚ 59,529.36 ▲ 1.84% USD/BRL 5.16 ▲ 0.01% USD/MXN 17.06 ▼ 0.24% USD/CLP 913.98 ▲ 0.04% USD/COP 3,140 ▲ 0.03% USD/PEN 3.36 ▼ 0.66% USD/ARS 1,493 ▲ 0.10% USD/UYU 40.27 ▲ 1.24% USD/PYG 5,939 ▲ 1.68% USD/BOB 11.64 ▼ 0.76% USD/DOP 58.34 ▲ 1.25% USD/CRC 445.92 ▲ 0.89% USD/GTQ 7.62 ▲ 2.21% USD/HNL 26.79 ▲ 1.57% USD/NIO 36.62 ▲ 0.69% USD/VES 762.44 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.28 — 0.00% USD/TTD 6.70 ▲ 0.61% EUR/BRL 5.95 ▲ 1.01% BRENT 88.88 ▼ 0.03% WTI 83.11 ▼ 0.11% IRON ORE 161.91 — — COPPER 6.61 ▲ 0.03% GOLD 4,461 ▲ 1.78% SILVER 65.59 ▲ 1.26% SOY 1,184 ▲ 3.20% CORN 480.50 ▲ 10.02% WHEAT 655.00 ▲ 3.93% COFFEE 317.25 ▼ 5.51% SUGAR 16.43 ▼ 1.79% ORANGE JUICE 138.55 ▼ 0.47% COTTON 85.03 ▲ 2.33% COCOA 5,719 ▲ 3.18% BEEF 223.60 ▼ 3.93% CATTLE 339.10 ▼ 3.16% LITHIUM 75.20 ▲ 1.47% PETR4 41.64 ▼ 0.05% VALE3 72.97 ▲ 0.83% ITUB4 38.60 ▼ 1.03% BBDC4 16.85 ▲ 0.36% ABEV3 14.89 ▼ 0.80% BBAS3 19.37 ▲ 0.47% B3SA3 14.26 ▼ 0.21% WEGE3 47.59 ▲ 0.49% PRIO3 59.14 ▼ 0.19% SUZB3 41.33 ▲ 2.35% RENT3 34.68 ▼ 0.09% AZZA3 15.89 ▼ 2.63% CSAN3 3.22 ▼ 1.83% RAIZ4 0.25 — 0.00% PCAR3 2.75 ▼ 0.36% GMAT3 3.65 ▼ 1.08% PSSA3 48.13 ▼ 0.54% CVCB3 1.33 ▼ 2.92% POSI3 3.36 ▲ 2.44% SLCE3 13.34 ▲ 0.30% NATU3 8.14 ▼ 0.73%
since 2009
Wednesday, September 23, 2026

Earnings Brazil

Brazil Q2 Earnings: Fleury Profit Jumps 46%; Energisa Swings to Loss

Brazil Q2 earnings split sharply as Fleury's profit jumped 46%, Wiz and PetroReconcavo weakened, and Energisa swung to a US$8 million loss.

By Carlos Silva · August 7, 2026 · 6 min read

The LatAm Brief

One email, every weekday morning. What moved in Latin American markets, politics and expat life.

Yesterday’s subject line: “68 strikes, 223 people. A UN expert says murder.”

Free. We send a confirmation link first — nothing arrives until you click it. Unsubscribe with one click in any edition. If you stop opening us for 30 days we stop sending by ourselves, as we assume the interest is no longer there. See our privacy policy. We never share your email.

Fleury-1
Fleury, Hypera, and Sequoia: Contrasting Fortunes in Brazil's Healthcare and Logistics Sectors.

Brazil · Business

Key Facts

Fleury led the group. Net income rose 45.7% to R$221.9 million (US$43.5 million) as revenue and EBITDA both grew by double digits.

Wiz’s adjusted measure fell. Consolidated adjusted profit declined 13.5% to R$101.0 million (US$19.8 million), while profit attributable to the parent rose 8.4%.

PetroReconcavo’s profit declined. Net income fell 14.9% to R$202.7 million (US$39.7 million), despite a wider EBITDA margin.

Energisa swung into the red. The utility posted a consolidated R$40 million (US$7.8 million) loss after a R$490 million (US$96.0 million) profit a year earlier.

Recurring utility profit also weakened. Energisa’s adjusted recurring profit dropped 80% to R$88 million (US$17.2 million) as financial expenses rose.

Capital returns continued. Fleury, PetroReconcavo and Energisa announced a combined R$569.3 million (US$111.6 million) in dividends or interest on equity.

The common thread was not growth or decline but the widening gap between operating performance and bottom-line profit: margins held up in several businesses while financing, regulation and accounting effects decided the final result.

Brazil Q2 Earnings: Fleury Profit Jumps 46%; Energisa Swings to Loss.
RT
Ask Rio Times
Latin American markets, currencies and companies.
Open the full Ask Rio Times →

Brazil’s latest second-quarter reports offered four different readings of the economy. Diagnostic-services group Fleury converted expansion into sharply higher profit. Insurance distributor Wiz Co absorbed regulatory disruption. Onshore producer PetroReconcavo protected its operating margin despite lower volumes. Energisa’s growing utility platform, meanwhile, was overwhelmed at the bottom line by financial and extraordinary accounting effects.

Company Q2 profit / loss Year on year Main signal
Fleury R$221.9m / US$43.5m +45.7% Broad-based growth
Wiz Co, adjusted consolidated R$101.0m / US$19.8m −13.5% Consigned-credit pressure
PetroReconcavo R$202.7m / US$39.7m −14.9% Price offset lower output
Energisa, reported −R$40.0m / −US$7.8m From R$490m profit Financial and accounting drag

Fleury Converts Expansion Into a 46% Profit Jump

Fleury delivered the clearest positive report. Net income increased 45.7% to R$221.9 million (US$43.5 million), while net revenue rose 14.4% to R$2.31 billion (US$452.8 million). EBITDA reached R$612.9 million (US$120.1 million), up 15.2%, with a 26.5% margin.

Growth extended across consumer diagnostics, hospital services and newer healthcare businesses. The company cited integration of acquisitions, organic expansion and efficiency gains. Net margin improved to 9.6%, showing that the revenue increase was not absorbed by the larger operating footprint.

The board also approved R$217.8 million (US$42.7 million) in interest on equity. The near-quarterly-profit distribution signals confidence in cash generation, although Fleury must keep acquisition integration and leverage disciplined as it continues combining organic and purchased growth.

Wiz Co’s Two Profit Measures Move in Opposite Directions

Wiz Co reported consolidated adjusted net income of R$101.0 million (US$19.8 million), down 13.5%. Net revenue excluding commissions fell 18.0% to R$235.3 million (US$46.1 million), and consolidated adjusted EBITDA declined 19.2% to R$152.8 million (US$30.0 million).

The weaker consolidated comparison reflected regulatory changes affecting payroll-deducted credit and a tougher environment in parts of the Bmg and BRB distribution network. Issued insurance premiums fell about 10% to R$879.7 million (US$172.4 million), while credit and consortium sales volume dropped 10.1% to R$3.3 billion (US$646.8 million).

Profit attributable to the controlling company tells a different story: it rose 8.4% to R$53.6 million (US$10.5 million). That figure excludes the portion belonging to minority investors and should not be confused with consolidated adjusted profit. Inter Seguros reached a record result, partially offsetting pressure elsewhere in the portfolio.

Live Company IntelligenceFleury S.A. — the full investor dossierInside: live share price, market cap, three-year financials, valuation, ESG and peer benchmarks — plus the latest Rio Times coverage.
F
◆ Live Company Intelligence
Fleury
SA: FLRY3FLRY3HealthcareDiagnostics & Research28,000 employees
R$11.95B
Market cap

Valuation & profitability

Market capR$11.95B
Revenue (TTM)R$8.79B
P / E ratio18.9
Profit margin8.0%
Return on equity12.6%

Price & risk

52-wk low
$13.01
52-wk high
$22.16
Beta (volatility)0.21
200-day average$16.53

Revenue trend · 6y

20202025
Latest R$8.29B

Ownership

Institutions28.3%
Shares outstanding544M

Dividend

Yield5.7%
Payout ratio90.7%
Fwd. annual$1.61
What Fleury does. Fleury S.A., together with its subsidiaries, engages in the provision of diagnostic imaging, clinical analysis, fertility, and infusions services in Brazil. It operates in two segments, Diagnostic Medicine and Integrated Medicine. The company also provides medical services in the areas of diagnostics, laboratory support, infusions, clinical analyses, health management, healthcare, assistance medicine,…
Data: RT fundamentals (FLRY3.SA) · figures in BRL · as of 22 Sep 2026More company intelligence →

PetroReconcavo Protects Margin as Production Falls

PetroReconcavo’s statutory net income fell 14.9% to R$202.7 million (US$39.7 million) from R$238.1 million (US$46.7 million). Net revenue was almost flat at R$807.9 million (US$158.4 million), while EBITDA increased 6% to R$396.1 million (US$77.6 million).

The EBITDA margin widened to 49.0% from 46.4%. Improved commercial terms for oil sold from the Potiguar asset and stronger realized pricing helped offset a 12% decline in average gross production to 24,100 barrels of oil equivalent per day. Free cash flow turned positive at R$74 million (US$14.5 million), from a R$99.9 million (US$19.6 million) outflow a year earlier.

Adjusted net income, which removes mark-to-market effects from hedges and related deferred tax, was lower still at R$104.6 million (US$20.5 million), down 33%. The board approved R$100 million (US$19.6 million) in interest on equity, but restoring production will be more important than quarterly derivative gains for sustaining future distributions.

Energisa’s Operating Growth Fails to Reach the Bottom Line

Energisa posted a consolidated net loss of R$40 million (US$7.8 million), reversing a R$490 million (US$96.0 million) profit in Q2 2025. The reported result included extraordinary accounting effects tied to the agreed sale of five transmission companies to Taesa and the resulting reclassification of those assets.

The recurring picture was also weak, though not loss-making. Adjusted recurring profit fell 80% to R$88 million (US$17.2 million), mainly because net financial expenses increased. Adjusted net revenue rose 4% to R$7.25 billion (US$1.42 billion), and recurring adjusted EBITDA edged 1% higher to R$1.95 billion (US$383.0 million).

Transmission, distributed generation and natural gas made positive EBITDA contributions, partially offsetting softness in electricity distribution and holding costs. Energisa approved R$251.5 million (US$49.3 million) in dividends, equivalent to R$0.50 per unit, for payment on August 24.

What the Four Reports Say About Brazil

Fleury’s result points to resilient private healthcare demand and successful consolidation. Wiz shows how quickly regulatory changes can disrupt fee-based financial distribution. PetroReconcavo demonstrates that stronger pricing can protect margins without solving declining field output. Energisa shows the burden that high financing costs can place on capital-intensive utilities even when operating revenue grows.

Investors should therefore look beyond the headline profit comparisons. The next tests are Fleury’s return on acquired capital, Wiz’s adaptation to new credit rules, PetroReconcavo’s production recovery and Energisa’s ability to reduce the financial drag on its expanding regulated asset base.

Background: Brazil Tax Reform Timeline: Tech Sector Faces 2026 Invoice Shock.

Background: Lula 39%, Flávio Bolsonaro 33% — Brazil’s Race in the July Polls.

Background: Fintechs and Digital Banks in Brazil 2026: Market Guide.

Background: Brazil Inflation Rate 2026: IPCA, Selic and What’s Next.

Frequently Asked Questions

Which company had the strongest Q2 result?

Fleury led the group, with net income rising 45.7% to R$221.9 million (US$43.5 million), revenue up 14.4% and EBITDA up 15.2%.

Why did Wiz Co’s adjusted profit fall?

Consolidated adjusted profit fell 13.5% to R$101.0 million (US$19.8 million) as payroll-credit regulatory changes and weaker activity at some distribution partners reduced revenue and EBITDA.

How did PetroReconcavo’s margin rise while profit fell?

Better oil-pricing and commercial terms lifted its EBITDA margin to 49.0%, but lower production, financial effects and other below-EBITDA items left statutory profit 14.9% lower.

Why did Energisa report a loss?

Energisa’s R$40 million (US$7.8 million) reported loss reflected extraordinary accounting effects from a transmission-asset sale as well as higher financial expenses; recurring adjusted profit remained positive at R$88 million (US$17.2 million).

Did the companies announce shareholder payments?

Fleury approved R$217.8 million (US$42.7 million) in interest on equity, PetroReconcavo approved R$100 million (US$19.6 million) in interest on equity, and Energisa approved R$251.5 million (US$49.3 million) in dividends.

Sources

This article was produced by The Rio Times’ automated newsroom system. How we use AI · Report an error

Read More from The Rio Times

The LatAm Brief

One email, every weekday morning. What moved in Latin American markets, politics and expat life.

Yesterday’s subject line: “68 strikes, 223 people. A UN expert says murder.”

Free. We send a confirmation link first — nothing arrives until you click it. Unsubscribe with one click in any edition. If you stop opening us for 30 days we stop sending by ourselves, as we assume the interest is no longer there. See our privacy policy. We never share your email.

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.